Depression risk associated with the use of 5α-reductase inhibitors versus α-blockers: A retrospective cohort study in South Korea.

Bora YeonAh Young SuhEunmi ChoiBong Gi KimEunsun NohSoo Youn ChungSoon Young Han

Published in: PloS one (2022)

The risk of depression associated with 5ARI was not meaningfully different from AB in Korea, which suggests that medical officials should provide the most appropriate medication for BPH patients by considering both treatment benefits and depression risk.

Keyphrases

depressive symptoms
sleep quality
end stage renal disease
healthcare
ejection fraction
newly diagnosed
emergency department
physical activity
patient reported outcomes
angiotensin converting enzyme
angiotensin ii
patient reported
smoking cessation